In vivo, triple intraperitoneal injections of the complexes II (3 x 200 mg/kg), III (3 x 100, 140, 180 mg/kg) or IV (3 x 160 mg/kg) markedly suppressed tumor development thus that the sizes of treated tumors were reduced to 42-48% related to control tumors ( 100%); these results point to the systemic character of the antitumor action by ferri cenium complexes in vivo. In vitro, all ferricenium complexes inhibited cellular proliferation to an equal extent; application of 10-5 m diminished the increase in cell number by 20-40%, applica tion of 10-4 m resulted in a total cessation of cellular proliferation. In comparison to cw-diamminedichloroplatinum(II), the cell growth-inhibiting effect of ferricenium complexes was less pronounced and required 10-to 50-fold higher concentration levels to evoke equivalent cytostasis.
Introduction
By the discovery of antitumor efficacy for cisdiamm inedichloroplatinum (II) [1] , intense studies searching for other inorganic and organometallic antitumor agents have been stimulated. These inves tigations revealed a series of unexpected results: It was shown that not only numerous com plexes con taining platinum or other platinum metals exhibit antitumor properties, but that also other quite differ ing com pounds are characterized by antiproliferative activity: (i) main group com pounds such as inorganic gallium salts [2] or organometallic tin compounds [3] ; (ii) early transition metal com plexes containing titanium or vanadium [4] ; and (iii) "m iddle" transi tion metal com pounds represented by som e fer ricenium com plexes [5] ,
The antitumor activity of the latter iron-containing com pounds was recently detected against fluid Ehr lich ascites tumor (E A T ) in mice [5] ; this activity is surprising and remarkable because the ferricenium com plexes fundamentally differ from known nonorganic antitumor agents by their ionic character and by the absence of a c/s-dihalometal moiety within the m olecules.
Abbreviations: Cp, C5H5, cyclopentadienyl ring ligand; EAT, Ehrlich ascites tumor.
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In the present investigation, we continued the studies into the cytostatic properties of ferricenium com plexes and exam ined (i) if the antitumor proper ties o f these com pounds are based on a systemic ef fect and (ii) if the antineoplastic activity shown in vivo is parallelled by cell growth-inhibiting effective ness in vitro.
Materials and Methods

Substances
The ferricenium com plexes* 
In vivo testing
The investigations in vivo were performed against solid E A T growing subcutaneously in the nuchal region of mice. On day 9, all animals were killed under ether anes thesia, the tumors were rem oved and w eighed with an accuracy of ± 1 mg. The T/C ratios were then calculated by relating the mean tumor weights of the treated groups to that of the appertaining control group.
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In vitro testing
The cell growth-inhibiting activity of ferricenium com plexes was investigated against E A T cells grow ing in vitro as permanent suspension culture; details of cell culture techniques have been described before [10] .
To these cell cultures containing about 4 x 104 cells/ml at the beginning of the experim ent, the fer ricenium com plexes were added in final concentra tions of 10~7, 10~6, 10-5, 10-4 and 10-3 m. Because of the good water solubility of the substances, no addi tion of a solute, e.g., o f dim ethylsulfoxide, was necessary. Four bottles were prepared for each con centration stage. Further four untreated cell popula tions served as controls for each ferricenium com pound.
Beginning immediately after drug addition, every 24 h up to 96 h, 0.5 ml of the cell suspensions were removed from each bottle and the cell number per ml was counted by use of a hem atocytom eter. The in crease in cell number per ml, expressed as a percent age of the cell number per ml, which was measured im mediately after addition of the antitumor agents, was then appointed for each cell population at 2 4 ,4 8 , 72 and 96 h. A fter determining the mean values and standard deviations for each concentration stage, the T/C ratios were calculated by relating as percentage the increase in cell number of treated populations to that of the appertaining control population at the various times of exposure. The values determined at 72 h are given in Table II .
Results
The in vivo data of the present study show som e of the ferricenium com plexes investigated to be capable of inhibiting the growth of solid E A T (Table I) th a t a T/C ratio o f 50% is generally considered to be th e crucial level for show ing activity against solid tu m o r system s [11] .
O n the o th e r h an d , the ferricenium com plexes I
and V failed to display grow th-suppressing activity against solid E A T (Table I) (Fig. 1) ; the cell numbers which were counted at 72 h am ounted to 60-80% related to those of control populations (Table I) 
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